Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Higher dopamine transporter density in Parkinson's disease patients with depression (2010)

  • Authors:
  • USP affiliated authors: AMARO JÚNIOR, EDSON - FM
  • USP Schools: FM
  • DOI: 10.1007/s00213-010-1867-y
  • Subjects: DOENÇA DE PARKINSON; DEPRESSÃO; TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE FÓTON ÚNICO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00213-010-1867-y (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s00213-010-1867-y (Fonte: Unpaywall API)

    Título do periódico: Psychopharmacology

    ISSN: 0033-3158,1432-2072



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Psychopharmacology

    ISSN: 0033-3158

    Citescore - 2017: 3.05

    SJR - 2017: 1.494

    SNIP - 2017: 0.872


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2181457-10
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FELICIO, Andre C; MORIYAMA, Tais S; GODEIRO JUNIOR, Clecio; et al. Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology, Berlin, v. 31, n. 2, p. 143-150, 2010. Disponível em: < http://dx.doi.org/10.1007/s00213-010-1867-y > DOI: 10.1007/s00213-010-1867-y.
    • APA

      Felicio, A. C., Moriyama, T. S., Godeiro Junior, C., Shih, M., Hoexter, M. Q. L., Borges, V., et al. (2010). Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology, 31( 2), 143-150. doi:10.1007/s00213-010-1867-y
    • NLM

      Felicio AC, Moriyama TS, Godeiro Junior C, Shih M, Hoexter MQL, Borges V, Silva SMA, Amaro Junior E, Andrade LA, Ferraz HB, Bressan RA. Higher dopamine transporter density in Parkinson's disease patients with depression [Internet]. Psychopharmacology. 2010 ; 31( 2): 143-150.Available from: http://dx.doi.org/10.1007/s00213-010-1867-y
    • Vancouver

      Felicio AC, Moriyama TS, Godeiro Junior C, Shih M, Hoexter MQL, Borges V, Silva SMA, Amaro Junior E, Andrade LA, Ferraz HB, Bressan RA. Higher dopamine transporter density in Parkinson's disease patients with depression [Internet]. Psychopharmacology. 2010 ; 31( 2): 143-150.Available from: http://dx.doi.org/10.1007/s00213-010-1867-y

    Referências citadas na obra
    Argyelan M, Szabo Z, Kanyo B, Tanacs A, Kovacs Z, Janka Z, Pavics L (2005) Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89:115–123
    Bressan RA, Shih MC, Hoexter MQ, Lacerda AL (2007) Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders? Rev Bras Psiquiatr 29:102–104
    Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D (1999) The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease. J Neurol Sci 166:141–151
    Brunswick DJ, Amsterdam JD, Mozley PD, Newber A (2003) Greater availability of brain dopamine transporters in major depression shown by [99mTc]TRODAT-1 SPECT imaging. Am J Psychiatry 160:1836–1841
    Felicio AC, Godeiro-Junior C, Shih MC, Borges V, Silva SM, Aguiar PD, Hoexter MQ, Barsottini OG, Andrade LA, Bressan RA, Ferraz HB (2010) Evaluation of patients with clinically unclear Parkinsonian syndromes submitted to brain SPECT imaging using the technetium-99 m labeled tracer TRODAT-1. J Neurol Sci 291:64–68
    Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, Sabri O (2009) Monoamine transporter availability in Parkinson’s disease patients with or without depression. Eur J Nucl Med Mol Imaging 36:428–435
    Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M (2007) Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson’s disease. Eur J Neurosci 25:3132–3136
    Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144:282–285
    Lehto SM, Tolmunen T, Kuikka J, Valkonen-Korhonen M, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Lehtonen J (2008) Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neurosci Lett 441:291–295
    Meyer JH, Krüger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH (2001) Lower dopamine transporter binding potential in striatum during depression. NeuroReport 12:4121–4125
    Murai T, Müller U, Werheid K, Sorger D, Reuter M, Becker T, von Cramon DY, Barthel H (2001) In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:222–228
    Rektorova I, Srovnalova H, Kubikova R, Prasek J (2008) Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson’s disease. Mov Disord 23:1580–1587
    Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322
    Rickards H (2005) Depression in neurological disordes: Parkinson’s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 76:48–52
    Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147:243–248
    Tumas V, Rodrigues GG, Farias TL, Crippa JA (2008) The accuracy of diagnosis of major depression in patients with Parkinson’s disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory. Arq Neuropsiquiatr 66:152–156
    Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. J Nucl Med 46:227–232
    Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008) Greater availability of dopamine transporters in patients with major depression—a dual-isotope SPECT study. Psychiatry Res 162:230–235